These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20803807)

  • 1. Proteomics: A discovery strategy for novel cancer biomarkers.
    Swami M
    Nat Rev Cancer; 2010 Sep; 10(9):597. PubMed ID: 20803807
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioinformatics Tools and Workflow to Select Blood Biomarkers for Early Cancer Diagnosis: An Application to Pancreatic Cancer.
    Vandenbrouck Y; Christiany D; Combes F; Loux V; Brun V
    Proteomics; 2019 Nov; 19(21-22):e1800489. PubMed ID: 31538697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.
    Chang L; Graham P; Hao J; Bucci J; Malouf D; Gillatt D; Li Y
    Cancer Lett; 2015 Dec; 369(2):289-97. PubMed ID: 26427840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerating Biomarker Discovery Through Electronic Health Records, Automated Biobanking, and Proteomics.
    Wells QS; Gupta DK; Smith JG; Collins SP; Storrow AB; Ferguson J; Smith ML; Pulley JM; Collier S; Wang X; Roden DM; Gerszten RE; Wang TJ
    J Am Coll Cardiol; 2019 May; 73(17):2195-2205. PubMed ID: 31047008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput targeted proteomics discovery approach and spontaneous reperfusion in ST-segment elevation myocardial infarction.
    Shavadia JS; Granger CB; Alemayehu W; Westerhout CM; Povsic TJ; Brener SJ; van Diepen S; Defilippi C; Armstrong PW
    Am Heart J; 2020 Feb; 220():137-144. PubMed ID: 31812755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics.
    Srivastava A; Creek DJ
    Proteomics; 2019 May; 19(10):e1700448. PubMed ID: 30353665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy.
    Deng J; Wang L; Ni J; Beretov J; Wasinger V; Wu D; Duan W; Graham P; Li Y
    Expert Rev Proteomics; 2016 Oct; 13(10):905-915. PubMed ID: 27598304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive phenotyping in multiple sclerosis: discovery based proteomics and the current understanding of putative biomarkers.
    O'Connor KC; Roy SM; Becker CH; Hafler DA; Kantor AB
    Dis Markers; 2006; 22(4):213-25. PubMed ID: 17124343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery.
    Hu S; Yen Y; Ann D; Wong DT
    Drug Discov Today; 2007 Nov; 12(21-22):911-6. PubMed ID: 17993408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of new proteomics strategies for biology and medicine.
    Domon B; Broder S
    J Proteome Res; 2004; 3(2):253-60. PubMed ID: 15113101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging proteomics biomarkers and prostate cancer burden in Africa.
    Adeola HA; Blackburn JM; Rebbeck TR; Zerbini LF
    Oncotarget; 2017 Jun; 8(23):37991-38007. PubMed ID: 28388542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for the lung cancer diagnosis and their advances in proteomics.
    Sung HJ; Cho JY
    BMB Rep; 2008 Sep; 41(9):615-25. PubMed ID: 18823584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research.
    Faria SS; Morris CF; Silva AR; Fonseca MP; Forget P; Castro MS; Fontes W
    Front Oncol; 2017; 7():13. PubMed ID: 28265552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Casting doubt on the traditional approach of cancer biomarker discovery through proteomics.
    Kondo T
    Expert Rev Proteomics; 2014 Feb; 11(1):9-12. PubMed ID: 24351084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerating protein biomarker discovery and translation from proteomics research for clinical utility.
    Chen J; Zheng N
    Bioanalysis; 2020 Oct; 12(20):1469-1481. PubMed ID: 33006485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics and drug discovery in cancer.
    Dias MH; Kitano ES; Zelanis A; Iwai LK
    Drug Discov Today; 2016 Feb; 21(2):264-77. PubMed ID: 26484434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
    Peng XQ; Wang F; Geng X; Zhang WM
    Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics approaches in cervical cancer: focus on the discovery of biomarkers for diagnosis and drug treatment monitoring.
    Kontostathi G; Zoidakis J; Anagnou NP; Pappa KI; Vlahou A; Makridakis M
    Expert Rev Proteomics; 2016 Aug; 13(8):731-45. PubMed ID: 27398979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
    de Wit M; Fijneman RJ; Verheul HM; Meijer GA; Jimenez CR
    Clin Biochem; 2013 Apr; 46(6):466-79. PubMed ID: 23159294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.